Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000217 · ClinicalTrials.gov registry record · Phase 2
Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
A Phase 2 study, sponsored by University of Kansas.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000217 is a Phase 2 study that has completed, run by University of Kansas.
The verdict
NCT00000217, a Phase 2 study, has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
Interventions
- DRUG Carbamazepine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1990-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000217
The ClinicalTrials.gov registry entry for NCT00000217 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Kansas, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carbamazepine is the first listed.
NCT00000217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000217 about?
NCT00000217 is a clinical study titled "Pharmacotherapy and Intensive Treatment of Drug Abuse - 1". The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
What is the current status of trial NCT00000217?
This trial is currently completed. It is a Phase 2 study. The study started on 1990-09.
What interventions are being tested in trial NCT00000217?
The interventions under investigation include: Carbamazepine (DRUG).
Who is sponsoring clinical trial NCT00000217?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.